2016-03-13T00:00:00.000-05:00
Exchange Commission,0.279859
Detwiler Fenton Investment,0.202859
52-week low,-0.625163
dividend yield,0.349
strong buy rating,0.403283
Asset Management LLC,0.22942
business’s stock,-0.270963
Walmsley LLC,0.310931
BKD Wealth Advisors,0.339113
stock,-8.52317E-4
recent filing,0.279859
InvestorPlace Broker Center,0.555736
average price target,-0.332991
biopharmaceutical company,0.490898
Thompson Siegel,0.310931
personal trading style,0.598412
research-based biopharmaceutical company,0.642682
target price,0.370067
recent reporting period,0.310931
Gilead Sciences Inc.,0.555178
research note,0.370067
average price,0.00668693
shares,0.0452509
executive vice president,0.214786
concise daily summary,0.447788
Gilead Sciences,0.324597
stock broker,0.245696
consensus rating,0.434497
John C. Martin,-0.240347
Wealth Advisors LLC,0.339113
new position,0.216139
chronic hepatitis,-0.646567
EVP Paul Rutherford,-0.30158
quarter,-0.159323
